Search research articles
Contact Us
Filters
Showing results (121-130 of 371) with videos related to
Page
of 38
Sort By:
British Journal of Cancer
|
October 1, 1983
Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer
A L Harris, M Dowsett, I E Smith, et al.
Cancer Practice
|
March 27, 2002
Integrating theory and practice. Conceptual frameworks of the CEFP
H Preskill, D W Compton, M Baizerman, et al.
British Journal of Cancer
|
December 1, 1983
Plasma calcitonin in small cell lung cancer: prognostic significance
A P Sappino, S Carter, M Ellison, et al.
Clinical Immunology (Orlando, Fla.)
|
September 10, 2002
Express subcutaneous IgG infusions: decreased time of delivery with maintained safety
S Hansen, R Gustafson, C I E Smith, et al.
Lancet (London, England)
|
April 1, 1995
Patient preference for extended palliative chemotherapy for non-small cell lung cancer
T F Hickish, I E Smith, G Middleton, et al.
Cancer Treatment Reviews
|
December 1, 1983
Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancer
I E Smith, R Stuart-Harris, N Pavlidis, et al.
NIDA Research Monograph
|
January 1, 1989
Characteristics of non-referred cocaine abusing mothers
I E Smith, S Moss-Wells, R Moeti, et al.
Lancet (London, England)
|
September 27, 1980
Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma
B M Bryant, M Jarman, H T Ford, et al.
British Journal of Cancer
|
October 1, 1986
Role of aminoglutethimide in male breast cancer
A L Harris, M Dowsett, R Stuart-Harris, et al.
British Journal of Cancer
|
September 1, 1984
Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer
M Dowsett, A L Harris, I E Smith, et al.
Page
of 38
Search research articles
Search
Showing results (121-130 of 371) with videos related to
Sort By:
Page
of 38
British Journal of Cancer
|
October 1, 1983
Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer
A L Harris, M Dowsett, I E Smith, et al.
Cancer Practice
|
March 27, 2002
Integrating theory and practice. Conceptual frameworks of the CEFP
H Preskill, D W Compton, M Baizerman, et al.
British Journal of Cancer
|
December 1, 1983
Plasma calcitonin in small cell lung cancer: prognostic significance
A P Sappino, S Carter, M Ellison, et al.
Clinical Immunology (Orlando, Fla.)
|
September 10, 2002
Express subcutaneous IgG infusions: decreased time of delivery with maintained safety
S Hansen, R Gustafson, C I E Smith, et al.
Lancet (London, England)
|
April 1, 1995
Patient preference for extended palliative chemotherapy for non-small cell lung cancer
T F Hickish, I E Smith, G Middleton, et al.
Cancer Treatment Reviews
|
December 1, 1983
Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancer
I E Smith, R Stuart-Harris, N Pavlidis, et al.
NIDA Research Monograph
|
January 1, 1989
Characteristics of non-referred cocaine abusing mothers
I E Smith, S Moss-Wells, R Moeti, et al.
Lancet (London, England)
|
September 27, 1980
Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma
B M Bryant, M Jarman, H T Ford, et al.
British Journal of Cancer
|
October 1, 1986
Role of aminoglutethimide in male breast cancer
A L Harris, M Dowsett, R Stuart-Harris, et al.
British Journal of Cancer
|
September 1, 1984
Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer
M Dowsett, A L Harris, I E Smith, et al.
Page
of 38